Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 4781-4790 of 10985

Edit search filters
  1. A Study on Pulmonary Mechanics of Playing Wind Instruments

    Rochester, MN

  2. A Study of the Impact of Decision Aids to Enhance Shared Decision Making for Diabetes

    Rochester, MN

  3. Specialty Compared to Oncology Delivered Palliative Care for Treating Acute Myeloid Leukemia

    Rochester, MN

  4. Ropivacaine Block Alone or with Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery

    Scottsdale/Phoenix, AZ

  5. Long-term Outcomes of May-Thurner Syndrome in Pediatric Patients

    Rochester, MN

  6. Improving Drug Delivery in Cystic Fibrosis Using Exercise

    Rochester, MN

  7. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer

  8. A Study of TRK-950 in Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ

  9. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer